Clinicopathologic and Genetic Characteristics of Breast Cancers in Patients with CHEK2 Alterations

被引:0
|
作者
Schwartz, Christopher [1 ]
Khorsandi, Nikka [1 ]
Blanco, Amie [2 ]
Mukhtar, Rita [1 ]
Chen, Yunn-Yi [1 ]
Krings, Gregor [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] UCSF Med Ctr, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
221
引用
收藏
页码:S208 / S209
页数:2
相关论文
共 50 条
  • [1] The landscape of somatic genetic alterations in breast cancers from CHEK2 germline mutation carriers
    Kumar, R.
    Pei, X.
    Selenica, P.
    Wen, H. Y.
    Powell, S.
    Robson, M.
    Riaz, N.
    Reis-Filho, J. S.
    Weigelt, B.
    Mandelker, D.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [2] The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
    Mandelker, Diana
    Kumar, Rahul
    Pei, Xin
    Selenica, Pier
    Setton, Jeremy
    Arunachalam, Sasi
    Ceyhan-Birsoy, Ozge
    Brown, David N.
    Norton, Larry
    Robson, Mark E.
    Wen, Hannah Y.
    Powell, Simon
    Riaz, Nadeem
    Weigelt, Britta
    Reis-Filho, Jorge S.
    [J]. JNCI CANCER SPECTRUM, 2019, 3 (02)
  • [3] Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers
    Williams, Louise H.
    Choong, David
    Johnson, Sandra A.
    Campbell, Ian G.
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (23) : 6967 - 6972
  • [4] Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants
    Christopher J. Schwartz
    Nikka Khorsandi
    Amie Blanco
    Rita A. Mukhtar
    Yunn-Yi Chen
    Gregor Krings
    [J]. Breast Cancer Research and Treatment, 2024, 204 : 171 - 179
  • [5] Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants
    Schwartz, Christopher J.
    Khorsandi, Nikka
    Blanco, Amie
    Mukhtar, Rita A.
    Chen, Yunn-Yi
    Krings, Gregor
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (01) : 171 - 179
  • [6] CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
    Isinger, A
    Bhat, M
    Borg, A
    Nilbert, M
    [J]. BMC CANCER, 2006, 6 (1)
  • [7] CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
    Anna Isinger
    Misha Bhat
    Ake Borg
    Mef Nilbert
    [J]. BMC Cancer, 6
  • [9] Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations
    Zdenek Kleibl
    Ondrej Havranek
    Jan Novotny
    Petra Kleiblova
    Pavel Soucek
    Petr Pohlreich
    [J]. Breast Cancer Research and Treatment, 2008, 112 : 159 - 164
  • [10] Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
    Toss, Angela
    Tenedini, Elena
    Piombino, Claudia
    Venturelli, Marta
    Marchi, Isabella
    Gasparini, Elisa
    Barbieri, Elena
    Razzaboni, Elisabetta
    Domati, Federica
    Caggia, Federica
    Grandi, Giovanni
    Combi, Francesca
    Tazzioli, Giovanni
    Dominici, Massimo
    Tagliafico, Enrico
    Cortesi, Laura
    [J]. GENES, 2021, 12 (05)